a developer of small molecule pharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that TBPH and SPRO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TBPH and SPRO's prices will move in lockstep.
Ticker / NAME | Correlation To TBPH | 1D Price Change % | ||
---|---|---|---|---|
TBPH | 100% | -3.03% | ||
SPRO - TBPH | 31% Poorly correlated | -2.19% | ||
ATNM - TBPH | 28% Poorly correlated | -6.03% | ||
IDYA - TBPH | 28% Poorly correlated | -3.52% | ||
ADPT - TBPH | 27% Poorly correlated | -4.47% | ||
ERAS - TBPH | 27% Poorly correlated | -5.19% | ||
More |
Ticker / NAME | Correlation To TBPH | 1D Price Change % |
---|---|---|
TBPH | 100% | -3.03% |
biotechnology theme (248 stocks) | 23% Poorly correlated | +5.56% |
pharmaceuticals theme (167 stocks) | 21% Poorly correlated | +0.82% |
north america theme (189 stocks) | 17% Poorly correlated | -0.16% |
small molecule theme (11 stocks) | 16% Poorly correlated | -1.27% |
innovating biotech theme (18 stocks) | 15% Poorly correlated | +0.21% |